Financials Kimberly-Clark Corporation

Equities

KMB

US4943681035

Personal Products

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
135.2 ^USD	-0.87%		+6.63%	+11.30%

Apr. 26	BNP Paribas Exane Adjusts Kimberly-Clark's Price Target to $126 From $120	MT
Apr. 26	Colgate-Palmolive raises sales growth target after strong Q1 results	RE

Valuation

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	47,153	45,861	48,124	45,815	41,063	45,537	-	-
Enterprise Value (EV) ¹	54,458	53,922	56,454	54,068	47,980	52,097	51,655	51,179
P/E ratio	22 x	19.6 x	26.7 x	23.7 x	23.3 x	19.8 x	18.9 x	17.8 x
Yield	3%	3.17%	3.19%	3.42%	3.88%	3.59%	3.73%	3.91%
Capitalization / Revenue	2.56 x	2.4 x	2.48 x	2.27 x	2.01 x	2.22 x	2.19 x	2.12 x
EV / Revenue	2.95 x	2.82 x	2.9 x	2.68 x	2.35 x	2.55 x	2.48 x	2.39 x
EV / EBITDA	13 x	12.3 x	15.7 x	16 x	12.9 x	13 x	12.5 x	11.7 x
EV / FCF	35.7 x	21.5 x	32.8 x	21.3 x	17.3 x	22.5 x	20.2 x	19 x
FCF Yield	2.8%	4.66%	3.05%	4.69%	5.79%	4.44%	4.94%	5.26%
Price to Book	-1,422 x	73 x	93.6 x	83.8 x	38.3 x	30.7 x	27.7 x	20.7 x
Nbr of stocks (in thousands)	342,806	340,137	336,717	337,492	337,941	336,709	-	-
Reference price ²	137.6	134.8	142.9	135.8	121.5	135.2	135.2	135.2
Announcement Date	1/23/20	1/25/21	1/26/22	1/25/23	1/24/24	-	-	-

¹USD in Million²USD

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	18,450	19,140	19,440	20,175	20,431	20,468	20,830	21,436
EBITDA ¹	4,198	4,378	3,602	3,371	3,711	3,997	4,125	4,365
EBIT ¹	3,281	3,582	2,836	2,617	2,958	3,205	3,323	3,504
Operating Margin	17.78%	18.71%	14.59%	12.97%	14.48%	15.66%	15.95%	16.35%
Earnings before Tax (EBT) ¹	2,650	2,930	2,225	2,340	2,021	2,866	2,983	3,240
Net income ¹	2,157	2,352	1,814	1,934	1,764	2,380	2,485	2,678
Net margin	11.69%	12.29%	9.33%	9.59%	8.63%	11.63%	11.93%	12.49%
EPS ²	6.240	6.870	5.350	5.720	5.210	6.838	7.158	7.604
Free Cash Flow ¹	1,527	2,512	1,723	2,536	2,776	2,315	2,553	2,690
FCF margin	8.28%	13.12%	8.86%	12.57%	13.59%	11.31%	12.25%	12.55%
FCF Conversion (EBITDA)	36.37%	57.38%	47.83%	75.23%	74.8%	57.93%	61.88%	61.62%
FCF Conversion (Net income)	70.79%	106.8%	94.98%	131.13%	157.37%	97.3%	102.74%	100.45%
Dividend per Share ²	4.120	4.280	4.560	4.640	4.720	4.850	5.046	5.289
Announcement Date	1/23/20	1/25/21	1/26/22	1/25/23	1/24/24	-	-	-

¹USD in Million²USD

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2
Net sales ¹	4,965	5,095	5,063	5,053	4,964	5,195	5,134	5,132	4,970	5,149	5,122	5,155	5,039	5,201	5,180
EBITDA ¹	805	817	813	853	898	975	916	963	857	1,083	972.8	1,002	943.8	1,116	1,029
EBIT ¹	611	629	621	665	712	787	727	774	670	898	778.2	803	737.5	900.7	805.7
Operating Margin	12.31%	12.35%	12.27%	13.16%	14.34%	15.15%	14.16%	15.08%	13.48%	17.44%	15.19%	15.58%	14.64%	17.32%	15.55%
Earnings before Tax (EBT) ¹	444	626	527	568	619	705	4	698	614	781	716.5	716.5	655.5	815	771
Net income ¹	357	523	437	467	507	566	102	587	509	647	583.4	596.2	542.7	676.5	631
Net margin	7.19%	10.26%	8.63%	9.24%	10.21%	10.9%	1.99%	11.44%	10.24%	12.57%	11.39%	11.57%	10.77%	13.01%	12.18%
EPS ²	1.060	1.550	1.290	1.380	1.500	1.670	0.3000	1.730	1.500	1.910	1.658	1.780	1.585	2.040	-
Dividend per Share ²	1.140	1.160	1.160	1.160	1.160	1.180	1.180	1.180	1.180	1.220	1.220	1.220	1.220	1.249	1.270
Announcement Date	1/26/22	4/22/22	7/26/22	10/25/22	1/25/23	4/25/23	7/25/23	10/24/23	1/24/24	4/23/24	-	-	-	-	-

¹USD in Million²USD

Estimates

Balance Sheet Analysis

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	7,305	8,061	8,330	8,253	6,917	6,560	6,118	5,643
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	1.74 x	1.841 x	2.313 x	2.448 x	1.864 x	1.641 x	1.483 x	1.293 x
Free Cash Flow ¹	1,527	2,512	1,723	2,536	2,776	2,315	2,553	2,690
ROE (net income / shareholders' equity)	-	894%	318%	359%	305%	208%	166%	136%
ROA (Net income/ Total Assets)	14.5%	16.2%	11.8%	10.6%	12.6%	13.9%	14.4%	14.7%
Assets ¹	14,901	14,553	15,309	18,177	13,986	17,067	17,236	18,161
Book Value Per Share ²	-0.1000	1.850	1.530	1.620	3.170	4.400	4.880	6.530
Cash Flow per Share ²	7.920	10.90	8.060	8.080	10.50	8.900	9.740	9.940
Capex ¹	1,209	1,217	1,007	876	766	840	868	929
Capex / Sales	6.55%	6.36%	5.18%	4.34%	3.75%	4.1%	4.17%	4.33%
Announcement Date	1/23/20	1/25/21	1/26/22	1/25/23	1/24/24	-	-	-

¹USD in Million²USD

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Kimberly-Clark Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

135.2 USD

Average target price

137.4 USD

Spread / Average Target

+1.56%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Sanitary Products

	1st Jan change	Capi.
KIMBERLY-CLARK CORPORATION	+11.30%	45.54B
UNICHARM CORPORATION	-9.06%	17.38B
HENGAN INTERNATIONAL GROUP COMPANY LIMITED	-9.81%	3.89B
VINDA INTERNATIONAL HOLDINGS LIMITED	+3.08%	3.6B
GILLETTE INDIA LIMITED	-3.52%	2.44B
C&S PAPER CO.,LTD	-13.60%	1.56B
CHONGQING BAIYA SANITARY PRODUCTS CO., LTD.	+40.30%	1.26B
HANGZHOU HAOYUE PERSONAL CARE CO., LTD	+13.83%	928M
ONTEX GROUP NV	+24.39%	820M
YUEN FOONG YU CONSUMER PRODUCTS CO., LTD.	+25.47%	436M

Sanitary Products